Navigation Links
Care Improvement Plus Achieves Top Scores for First SNP Evaluation Measures
Date:11/19/2008

BALTIMORE, Nov. 19 /PRNewswire/ -- Care Improvement Plus, one of the nation's largest chronic condition Special Needs Plans (SNPs), announced today that it has received top scores from the Centers for Medicare & Medicaid Services (CMS) in the evaluation of its structure and process measures. The measures are the first in a series of new requirements evaluating the performance of SNPs in providing high quality care and improving health outcomes for Medicare beneficiaries.

"We are thrilled to be recognized for the comprehensive nature of our approach to managing the care of our chronically ill members," said Frederick C. Dunlap, board chairman and chief executive officer of XLHealth, which owns and operates Care Improvement Plus. "The successful completion of these reporting requirements is an important first step toward securing a permanent place within Medicare for special needs plans."

In December of 2007, the Centers for Medicare & Medicaid Services announced plans to contract with the National Committee for Quality Assurance (NCQA) to implement a three phase strategy to evaluate SNPs. The first phase of the evaluation process includes a review of a set of structure and process measures that are scored by a team of clinical quality experts. Plans are scored based on their ability to meet required elements concerning case management, member satisfaction, and clinical quality improvements. In addition, during the first phase 13 HEDIS(R) measures will be used to further evaluate the quality of care SNPs are providing.

Created by the federal government through the Medicare Modernization Act, SNPs are Medicare Advantage Prescription Drug plans designed to meet the unique needs of certain groups of Medicare beneficiaries, including those with chronic health conditions, those that reside in institutions, and those that are dual-eligible.

Care Improvement Plus offers a variety of services and added benefits to help members manage their conditions and prevent complications. Care Improvement Plus offers services exclusively to approximately 1.4 million Medicare beneficiaries in the states of Maryland, Arkansas, Georgia, Missouri, South Carolina and Texas living with diabetes, heart failure, end-stage renal disease (ESRD) and/or chronic obstructive pulmonary disease (COPD).

About Care Improvement Plus

Care Improvement Plus (http://www.careimprovementplus.com), a special needs health plan that focuses on the unique healthcare needs of chronically ill Medicare beneficiaries, provides Medicare Advantage health plan coverage, along with a tailored Medicare Part D drug benefit and care management services, to Medicare beneficiaries living with heart failure, diabetes, chronic obstructive pulmonary disease and/or end-stage renal disease. Care Improvement Plus also provides a variety of services designed to support physicians' efforts to care for their chronically ill patients.

About XLHealth

XLHealth (http://www.xlhealth.com), a Baltimore-based organization focused on improving the healthcare of chronically ill seniors, is the owner and operator of Care Improvement Plus, one of the nation's largest chronic condition special needs plans. Care Improvement Plus provides a complete Medicare Advantage Part D health plan including disease management services to Medicare beneficiaries living with heart failure, diabetes, chronic obstructive pulmonary disease and/or end-stage renal disease. XLHealth has earned Full Accreditation from the National Committee for Quality Assurance (NCQA) under its standards for patient and practitioner-oriented accreditation of disease management programs.

HEDIS(R) is a registered trademark of NCQA.


'/>"/>
SOURCE Care Improvement Plus
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Broad-based group of physicians calls for improvement in stroke treatment
2. Home Care Agencies Responding to Patients Needs - Still Have Room for Improvement
3. Eclipsys User Network Brings Eclipsys Clients Together to Share Outcome Improvement Strategies
4. National Award Recognizes Delmarva Foundation and CareFirst BlueCross BlueShield Quality Improvement Efforts
5. New study of Concerta showed significant improvement of ADHD symptom management in adults
6. Education program leads to lasting improvement of cancer knowledge in African Americans
7. Education program leads to lasting improvement of cancer knowledge in African-Americans
8. Dilon Technologies Explores Improvements in Molecular Breast Imaging
9. Eclipsys Sunrise Radiology Helps Trinitas Hospital Achieve Financial Outcome Improvements
10. Long-term improvement seen with hip replacement
11. Monotherapy BYETTA(R) Showed Significant Improvement in Glucose Control and Weight Loss in Adults with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... ... 08, 2016 , ... Stephanie Hebert Insurance Agency, serving families ... new charity campaign. As part of their ongoing community involvement program, funds are ... that children deserve a voice, and in the spirit of neighbors helping neighbors ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... expansion into Canada to provide its range of unique and advantaged protective ... Quebec City that will provide bilingual customer service and marketing support. A new ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... announced today that nominations will be accepted February 8, 2016 through May ... , Awards include the Information Security Executive® of the Year, which recognizes ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... lower incidence rate of type 2 diabetes in the GrassrootsHealth cohort with substantially ... to make a change in public health,” states Carole Baggerly, Director of GrassrootsHealth, ...
(Date:2/8/2016)... , ... February 08, 2016 , ... The schedule ... in this country. The AutismOne 2016 Conference, which is being held May 25-29 at ... won’t hear elsewhere about helpful interventions and causes of chronic illness in children. , ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... , Feb. 8, 2016  Sangamo BioSciences, ... therapeutic genome editing, announced that the U.S. Food ... Investigational New Drug (IND) application for SB-318, a ... therapy for Mucopolysaccharidosis Type I (MPS I). The ... Sangamo to initiate a Phase 1/2 clinical study ...
(Date:2/8/2016)... February 8, 2016 ... published by Allied Market Research titled, "World ... Forecasts, 2014-2020", estimates the world synthetic biology market ... and sequencing technology segment would continue to lead ... tools segment, collectively, held around half of the ...
(Date:2/8/2016)... HOUSTON , 8. Februar 2016 /PRNewswire/ ... veröffentlichte heute eine Infografik mit dem Titel ... ganzen Welt), mit der der Krankheit gegenüber ... die dazu ermutigen soll, Medikamentenresistenz bei Epilepsie ... der allgemeinen Diskussion zu machen. Mithilfe der ...
Breaking Medicine Technology: